Differentiation of cisplatin uptake within a population of cancer cells – how to “crack this nut” using single-cell ICP-MS
Abstract
A versatile tool to unravel the uptake diversity of a front-line anticancer drug, cisplatin, within a cancer cell population is proposed herein based on single-cell inductively coupled plasma mass spectrometry. The interested researcher is provided with a tutorial to help adapt such cutting-edge methodology and know-how to reliable data processing.

Please wait while we load your content...